Shana Traina

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study

Martin Dreyling, Wojciech Jurczak, Mats Jerkeman et al. · The Lancet · 2015 · 462 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S.

David H. Henry, Hema N. Viswanathan, Eric P. Elkin et al. · Supportive Care in Cancer · 2008 · 387 citations

Medicine, Oncology, Cancer Epidemiology +13

The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes

Helena W. Rodbard, Anne L. Peters, April Slee et al. · Diabetes Care · 2016 · 94 citations

Medicine, Pharmacology, Pharmacotherapy +17

A call to action to inform patient‐centred approaches to obesity management: Development of a disease‐illness model

John Fastenau, Ronette L. Kolotkin, Ken Fujioka et al. · Clinical Obesity · 2019 · 75 citations · Full text

Agriculture, Health Sciences, Clinical Nutrition +16

Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept.

Annelies Boonen, Vaishali Patel, Shana Traina et al. · PubMed · 2008 · 36 citations

Pharmacy, Internal Medicine, Pharmacotherapy +17